Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Fluids and Barriers of the CNS
Published in: Fluids and Barriers of the CNS 1/2014

Open Access 01-12-2014 | Review

Neural stem cells: are they the hope of a better life for patients with fetal-onset hydrocephalus?

Author: Montserrat Guerra

Published in: Fluids and Barriers of the CNS | Issue 1/2014

Login to get access

Abstract

I was honored to be awarded the Casey Holter Essay Prize in 2013 by the Society for Research into Hydrocephalus and Spina Bifida. The purpose of the prize is to encourage original thinking in a way to improve the care of individuals with spina bifida and hydrocephalus. Having kept this purpose in mind, I have chosen the title: Neural stem cells, are they the hope of a better life for patients with fetal-onset hydrocephalus? The aim is to review and discuss some of the most recent and relevant findings regarding mechanisms leading to both hydrocephalus and abnormal neuro/gliogenesis. By looking at these outcome studies, it is hoped that we will recognize the potential use of neural stem cells in the treatment of hydrocephalus, and so prevent the disease or diminish/repair the associated brain damage.
Appendix
Available only for authorised users
Literature
1.
Del Bigio MR: Neuropathology and structural changes in hydrocephalus. Dev Disabil Res Rev. 2010, 16: 16-22. 10.1002/ddrr.94.CrossRefPubMed
2.
3.
Miyan JA, Nabiyouni M, Zendah M: Development of the brain: a vital role for cerebrospinal fluid. Can J Physiol Pharmacol. 2003, 81: 317-328. 10.1139/y03-027.CrossRefPubMed
4.
Parada C, Martín C, Alonso MI, Moro JA, Bueno D, Gato A: Embryonic cerebrospinal fluid collaborates with the isthmic organizer to regulate mesencephalic gene expression. J Neurosci Res. 2005, 82: 333-345. 10.1002/jnr.20618.CrossRefPubMed
5.
Sawamoto K, Wichterle H, Gonzalez-Perez O, Cholfin JA, Yamada M, Spassky N, Murcia NS, Garcia-Verdugo JM, Marin O, Rubenstein JL, Tessier-Lavigne M, Okano H, Alvarez-Buylla A: New neurons follow the flow of cerebrospinal fluid in the adult brain. Science. 2006, 311: 629-632. 10.1126/science.1119133.CrossRefPubMed
6.
Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD: Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res. 2008, 5: 10-10.1186/1743-8454-5-10.PubMedCentralCrossRefPubMed
7.
Lehtinen MK, Zappaterra MW, Chen X, Yang YJ, Hill AD, Lun M, Maynard T, Gonzalez D, Kim S, Ye P, D’Ercole AJ, Wong ET, LaMantia AS, Walsh CA: The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. Neuron. 2011, 69: 893-905. 10.1016/j.neuron.2011.01.023.PubMedCentralCrossRefPubMed
8.
Williams MA, McAllister JP, Walker ML, Kranz DA, Bergsneider M, Del Bigio MR, Fleming L, Frim DM, Gwinn K, Kestle JR, Luciano MG, Madsen JR, Oster-Granite ML, Spinella G: Priorities for hydrocephalus research: report from a National Institutes of Health-sponsored workshop. J Neurosurg. 2007, 107 (5 Suppl): 345-357.PubMed
9.
Carter CS, Vogel TW, Zhang Q, Seo S, Swiderski RE, Moninger TO, Cassell MD, Thedens DR, Keppler-Noreuil KM, Nopoulos P, Nishimura DY, Searby CC, Bugge K, Sheffield VC: Abnormal development of NG2+PDGFR-α+ neural progenitor cells leads to neonatal hydrocephalus in a ciliopathy mouse model. Nat Med. 2012, 18: 1797-1804. 10.1038/nm.2996.PubMedCentralCrossRefPubMed
10.
Domínguez-Pinos MD, Páez P, Jiménez AJ, Weil B, Arráez MA, Pérez-Fígares JM, Rodríguez EM: Ependymal denudation and alterations of the subventricular zone occur in human fetuses with a moderate communicating hydrocephalus. J Neuropathol Exp Neurol. 2005, 64: 595-604. 10.1097/01.jnen.0000171648.86718.bb.CrossRefPubMed
11.
Guerra M, Sival DA, Jiménez A, Domínguez-Pinos MD, den Dunnen WFA, Bátiz LF, Pérez-Figares JM, Rodríguez EM: Defects in cell-cell junctions lead to neuroepithelial/ependymal denudation in the telencephalon of human hydrocephalic foetuses. Cerebrospinal Fluid Res. 2010, 7 (Suppl 1): S56-10.1186/1743-8454-7-S1-S56.PubMedCentralCrossRef
12.
Rodríguez EM, Guerra M, Vío K, Gonzalez C, Ortloff A, Bátiz LF, Rodríguez S, Jara MC, Muñoz RI, Ortega E, Jaque J, Guerra F, Sival DA, den Dunnen WFA, Jiménez A, Domínguez-Pinos MD, Pérez-Figares JM, McAllister JP, Johanson C: A cell junction pathology of neural stem cells leads to abnormal neurogenesis and hydrocephalus. Biol Res. 2012, 45: 231-242. 10.4067/S0716-97602012000300005.CrossRefPubMed
13.
Yung YC1, Mutoh T, Lin ME, Noguchi K, Rivera RR, Choi JW, Kingsbury MA, Chun J: Lysophosphatidic acid signaling may initiate fetal hydrocephalus. Sci Transl Med. 2011, 3: 99ra87-PubMedCentralCrossRefPubMed
14.
Weller S, Gärtner J: Genetic and clinical aspects of X-linked hydrocephalus (L1 disease): Mutations in the L1CAM gene. Hum Mutat. 2001, 18: 1-12. 10.1002/humu.1144.CrossRefPubMed
15.
16.
Jiménez AJ, Tomé M, Páez P, Wagner C, Rodríguez S, Fernández-Llebrez P, Rodríguez EM, Pérez-Fígares JM: A programmed ependymal denudation precedes congenital hydrocephalus in the hyh mutant mouse. J Neuropathol Exp Neurol. 2001, 60: 1105-1119.PubMed
17.
Wagner C, Bátiz LF, Rodríguez S, Jiménez AJ, Páez P, Tomé M, Pérez-Fígares JM, Rodríguez EM: Cellular mechanisms involved in the stenosis and obliteration of the cerebral aqueduct of hyh mutant mice developing congenital hydrocephalus. J Neuropathol Exp Neurol. 2003, 62: 1019-1040.PubMed
18.
Páez P, Bátiz LF, Roales-Buján R, Rodríguez-Pérez LM, Rodríguez S, Jiménez AJ, Rodríguez EM, Pérez-Fígares JM: Patterned neuropathologic events occurring in hyh congenital hydrocephalic mutant mice. J Neuropathol Exp Neurol. 2007, 66: 1082-1092. 10.1097/nen.0b013e31815c1952.CrossRefPubMed
19.
Sival DA, Guerra M, den Dunnen WFA, Bátiz LF, Alvial G, Rodríguez EM: Neuroependymal denudation is in progress in full-term human foetal spina bifida aperta. Brain Pathol. 2011, 21: 163-179. 10.1111/j.1750-3639.2010.00432.x.CrossRefPubMed
20.
de Wit OA, den Dunnen WF, Sollie KM, Muñoz RI, Meiners LC, Brouwer OF, Rodríguez EM, Sival DA: Pathogenesis of cerebral malformations in human fetuses with meningomyelocele. Cerebrospinal Fluid Res. 2008, 5: 4-10.1186/1743-8454-5-4.PubMedCentralCrossRefPubMed
21.
Ferland RJ, Bátiz LF, Neal J, Lian G, Bundock E, Lu J, Hsiao YC, Diamond R, Mei D, Banham AH, Brown PJ, Vanderburg CR, Joseph J, Hecht JL, Folkerth R, Guerrini R, Walsh CA, Rodríguez EM, Sheen VL: Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia. Hum Mol Genet. 2009, 18: 497-516.PubMedCentralCrossRefPubMed
22.
Guerrini R, Barba C: Malformations of cortical development and aberrant cortical networks: epileptogenesis and functional organization. J Clin Neurophysiol. 2010, 27: 372-379. 10.1097/WNP.0b013e3181fe0585.CrossRefPubMed
23.
Sheen VL, Basel-Vanagaite L, Goodman JR, Scheffer IE, Bodell A, Ganesh VS, Ravenscroft R, Hill RS, Cherry TJ, Shugart YY, Barkovich J, Straussberg R, Walsh CA: Etiological heterogeneity of familial periventricular heterotopia and hydrocephalus. Brain Dev. 2004, 26: 326-334. 10.1016/j.braindev.2003.09.004.CrossRefPubMed
24.
Parrini E, Ramazzotti A, Dobyns WB, Mei D, Moro F, Veggiotti P, Marini C, Brilstra EH, Dalla Bernardina B, Goodwin L, Bodell A, Jones MC, Nangeroni M, Palmeri S, Said E, Sander JW, Striano P, Takahashi Y, Van Maldergem L, Leonardi G, Wright M, Walsh CA, Guerrini R: Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. Brain. 2006, 129 (Pt 7): 1892-1906.CrossRefPubMed
25.
Liu JS: Molecular genetics of neuronal migration disorders. Curr Neurol Neurosci Rep. 2011, 11: 171-178. 10.1007/s11910-010-0176-5.CrossRefPubMed
26.
Conti V, Carabalona A, Pallesi-Pocachard E, Parrini E, Leventer RJ, Buhler E, McGillivray G, Michel FJ, Striano P, Mei D, Watrin F, Lise S, Pagnamenta AT, Taylor JC, Kini U, Clayton-Smith J, Novara F, Zuffardi O, Dobyns WB, Scheffer IE, Robertson SP, Berkovic SF, Represa A, Keays DA, Cardoso C, Guerrini R: Periventricular heterotopia in 6q terminal deletion syndrome: role of the C6orf70 gene. Brain. 2013, 136 (Pt 11): 3378-3394.CrossRefPubMed
27.
Chae TH, Kim S, Marz KE, Hanson PI, Walsh CA: The hyh mutation uncovers roles for Snap in apical protein localization and control of neural cell fate. Nat Genet. 2004, 36: 264-270. 10.1038/ng1302.CrossRefPubMed
28.
Sato O, Yamguchi T, Kittaka M, Toyama H: Hydrocephalus and epilepsy. Childs Nerv Syst. 2001, 17 (1–2): 76-86.CrossRefPubMed
29.
30.
Bourgeois M, Sainte-Rose C, Cinalli G, Maixner W, Malucci C, Zerah M, Pierre-Kahn A, Renier D, Hoppe-Hirsch E, Aicardi J: Epilepsy in children with shunted hydrocephalus. J Neurosurg. 1999, 90: 274-281. 10.3171/jns.1999.90.2.0274.CrossRefPubMed
31.
Klepper J, Büsse M, Strassburg HM, Sörensen N: Epilepsy in shunt-treated hydrocephalus. Dev Med Child Neurol. 1998, 40: 731-736.CrossRefPubMed
32.
Santi MR, Golden JA: Periventricular heterotopia may result from radial glial fiber disruption. J Neuropathol Exp Neurol. 2001, 60: 856-862.PubMed
33.
Andressen C: Neural stem cells: From neurobiology to clinical applications. Curr Pharm Biotechnol. 2013, 14: 20-28.PubMed
34.
Dutta S, Singh G, Sreejith S, Mamidi MK, Husin JM, Datta I, Pal R, Das AK: Cell therapy: the final frontier for treatment of neurological diseases. CNS Neurosci Ther. 2013, 19: 5-11. 10.1111/cns.12027.CrossRefPubMed
35.
Korecka JA, Verhaagen J, Hol EM: Cell-replacement and gene-therapy strategies for Parkinson’s and Alzheimer’s disease. Regen Med. 2007, 2: 425-446. 10.2217/17460751.2.4.425.CrossRefPubMed
36.
Gibson SA, Gao GD, McDonagh K, Shen S: Progress on stem cell research towards the treatment of Parkinson’s disease. Stem Cell Res Ther. 2012, 3: 11-10.1186/scrt102.PubMedCentralCrossRefPubMed
37.
Martino G, Franklin RJ, Baron Van Evercooren A, Kerr DA: Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol. 2010, 6: 247-255. 10.1038/nrneurol.2010.35.CrossRefPubMed
38.
Reynolds B, Weiss S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992, 255: 1707-1710. 10.1126/science.1553558.CrossRefPubMed
39.
Jensen JB, Parmar M: Strengths and limitations of the neurosphere culture system. Mol Neurobiol. 2006, 34 (3): 153-161. 10.1385/MN:34:3:153.CrossRefPubMed
40.
Pastrana E, Silva-Vargas V, Doetsch F: Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell. 2011, 8: 486-498. 10.1016/j.stem.2011.04.007.PubMedCentralCrossRefPubMed
41.
Gil-Perotín S, Duran-Moreno M, Cebrián-Silla A, Ramírez M, García-Belda P, García-Verdugo JM: Adult neural stem cells from the subventricular zone: a review of the neurosphere assay. Anat Rec (Hoboken). 2013, 296: 1435-1452.CrossRef
42.
Altman J, Das GD: Autoradiographic and histological studies of postnatal neurogenesis. I. A longitudinal investigation of the kinetics, migration and transformation of cells incorporating tritiated thymidine in neonate rats, with special reference to postnatal neurogenesis in some brain regions. J Comp Neurol. 1966, 126: 337-389. 10.1002/cne.901260302.CrossRefPubMed
43.
Hsu YC, Chen SL, Wang DY, Chiu IM: Stem cell-based therapy in neural repair. Biomed J. 2013, 36: 98-105. 10.4103/2319-4170.113226.CrossRefPubMed
44.
Fleiss B, Guillot PV, Titomanlio L, Baud O, Hagberg H, Gressens P: Stem cell therapy for neonatal brain Injury. Clin Perinatol. 2014, 41: 133-148. 10.1016/j.clp.2013.09.002.CrossRefPubMed
45.
Watanabe M, Kang YJ, Davies LM, Meghpara S, Lau K, Chung CY, Kathiriya J, Hadjantonakis AK, Monuki ES: BMP4 sufficiency to induce choroid plexus epithelial fate from embryonic stem cell-derived neuroepithelial progenitors. J Neurosci. 2012, 32: 15934-15945. 10.1523/JNEUROSCI.3227-12.2012.PubMedCentralCrossRefPubMed
46.
De Wert G, Mummery C: Human embryonic stem cells: research, ethics and policy. Hum Reprod. 2003, 18: 672-682. 10.1093/humrep/deg143.CrossRefPubMed
47.
de Sousa C, Lopes SM, Roelen BA: On the formation of germ cells: the good, the bad and the ugly. Differentiation. 2010, 79: 131-40. 10.1016/j.diff.2009.11.003.CrossRef
48.
Yang X, Smith SL, Tian XC, Lewin HA, Renard JP, Wakayama T: Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet. 2007, 39: 295-302. 10.1038/ng1973.CrossRefPubMed
49.
Das M, Sundell IB, Koka PS: Adult mesenchymal stem cells and their potency in the cell-based therapy. J Stem Cells. 2013, 8: 1-16.PubMed
50.
Murphy SV, Atala A: Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells. Semin Reprod Med. 2013, 31: 62-68. 10.1055/s-0032-1331799.CrossRefPubMed
51.
Castillo-Melendez M, Yawno T, Jenkin G, Miller SL: Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells. Front Neurosci. 2013, 7: 194-PubMedCentralCrossRefPubMed
52.
Stagg J, Galipeau J: Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation. Curr Mol Med. 2013, 13: 856-867. 10.2174/1566524011313050016.CrossRefPubMed
53.
Lotfinegad P, Shamsasenjan K, Movassaghpour A, Majidi J, Baradaran B: Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy. Adv Pharm Bull. 2014, 4: 5-13.PubMedCentralPubMed
54.
Martini MM, Jeremias Tda S, Kohler MC, Marostica LL, Trentin AG, Alvarez-Silva M: Human placenta-derived mesenchymal stem cells acquire neural phenotype under the appropriate niche conditions. DNA Cell Biol. 2013, 32: 58-65. 10.1089/dna.2012.1807.CrossRefPubMed
55.
Chen G, Wang Y, Xu Z, Fang F, Xu R, Wang Y, Hu X, Fan L, Liu H: Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. J Transl Med. 2013, 11: 21-10.1186/1479-5876-11-21.PubMedCentralCrossRefPubMed
56.
Rivera FJ, Aigner L: Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis. Biol Res. 2012, 45: 257-268. 10.4067/S0716-97602012000300007.CrossRefPubMed
57.
Li H, Gao F, Ma L, Jiang J, Miao J, Jiang M, Fan Y, Wang L, Wu D, Liu B, Wang W, Lui VC, Yuan Z: Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta. J Cell Mol Med. 2012, 16: 1606-1617. 10.1111/j.1582-4934.2011.01470.x.PubMedCentralCrossRefPubMed
58.
Bilic J, Izpisua Belmonte JC: Concise review: induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?. Stem Cells. 2012, 30: 33-41. 10.1002/stem.700.CrossRefPubMed
59.
Jung YW, Hysolli E, Kim KY, Tanaka Y, Park IH: Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Curr Opin Neurol. 2012, 25: 125-130. 10.1097/WCO.0b013e3283518226.PubMedCentralCrossRefPubMed
60.
Wang H, Doering LC: Induced pluripotent stem cells to model and treat neurogenetic disorders. Neural Plast. 2012, 2012: 346053-PubMedCentralPubMed
61.
Nori S, Tsuji O, Okada Y, Toyama Y, Okano H, Nakamura M: Therapeutic potential of induced pluripotent stem cells for spinal cord injury. Brain Nerve. 2012, 64: 17-27.PubMed
62.
Shtrichman R, Germanguz I, Itskovitz-Eldor J: Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine. Curr Mol Med. 2013, 13: 792-805. 10.2174/1566524011313050010.CrossRefPubMed
63.
Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, Homfray T, Penninger JM, Jackson AP, Knoblich JA: Cerebral organoids model human brain development and microcephaly. Nature. 2013, 501: 373-379. 10.1038/nature12517.CrossRefPubMed
64.
Somera KC, Jones HC: Reduced subcommissural organ glycoprotein immunoreactivity precedes aqueduct closure and ventricular dilatation in H-Tx rat hydrocephalus. Cell Tissue Res. 2004, 315: 361-373. 10.1007/s00441-003-0843-9.CrossRefPubMed
65.
Ortloff AR, Vío K, Guerra M, Jaramillo K, Kaehne T, Jones H, McAllister JP, Rodríguez E: Role of the subcommissural organ in the pathogenesis of congenital hydrocephalus in the HTx rat. Cell Tissue Res. 2013, 352: 707-725. 10.1007/s00441-013-1615-9.CrossRefPubMed
66.
Bystron I, Blakemore C, Rakic P: Development of the human cerebral cortex: Boulder Committee revisited. Nat Rev Neurosci. 2008, 9: 110-122. 10.1038/nrn2252.CrossRefPubMed
67.
68.
Clancy B, Darlington RB, Finlay BL: Translating developmental time across mammalian species. Neuroscience. 2001, 105: 7-17. 10.1016/S0306-4522(01)00171-3.CrossRefPubMed
69.
Clancy B, Kersh B, Hyde J, Darlington RB, Anand KJ, Finlay BL: Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics. 2007, 5: 79-94.CrossRefPubMed
70.
71.
Scully SM, Mallon M, Kerr JC, Ludzia-De Angelis A: A fetal myelomeningocele repair: a new standard of care. AORN J. 2012, 96: 175-195. 10.1016/j.aorn.2012.05.009.CrossRefPubMed
72.
Rodrigues HC, van den Berg PP, Düwell M: Dotting the I’s and crossing the T’s: autonomy and/or beneficence? The ‘fetus as a patient’ in maternal-fetal surgery. J Med Ethics. 2013, 39: 219-223. 10.1136/medethics-2012-100781.CrossRefPubMed
73.
Johnson MP1, Sutton LN, Rintoul N, Crombleholme TM, Flake AW, Howell LJ, Hedrick HL, Wilson RD, Adzick NS: Fetal myelomeningocele repair: short-term clinical outcomes. Am J Obstet Gynecol. 2003, 189: 482-487. 10.1067/S0002-9378(03)00295-3.CrossRefPubMed
74.
Adzick NS, Thom EA, Spong CY, Brock JW, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D’Alton ME, Farmer DL: A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011, 364: 993-1004. 10.1056/NEJMoa1014379.PubMedCentralCrossRefPubMed
75.
Roybal JL, Santore MT, Flake AW: Stem cell and genetic therapies for the fetus. Semin Foetal Neonatal Med. 2010, 15: 6-
76.
Merianos D, Heaton T, Flake AW: In utero hematopoietic stem cell transplantation: progress toward clinical application. Biol Blood Marrow Transplant. 2008, 14: 729-740. 10.1016/j.bbmt.2008.02.012.CrossRefPubMed
77.
Fauza DO, Jennings RW, Teng YD, Snyder EY: Neural stem cell delivery to the spinal cord in an ovine model of foetal surgery for spina bifida. Surgery. 2008, 144: 367-373. 10.1016/j.surg.2008.05.009.CrossRefPubMed
78.
Martino G, Pluchino S: The therapeutic potential of neural stem cells. Nat Rev Neurosci. 2006, 7: 395-406.CrossRefPubMed
79.
De Feo D, Merlini A, Laterza C, Martino G: Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection. Curr Opin Neurol. 2012, 25: 322-333. 10.1097/WCO.0b013e328352ec45.CrossRefPubMed
80.
Cossetti C, Alfaro-Cervello C, Donegà M, Tyzack G, Pluchino S: New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies. Cell Tissue Res. 2012, 349: 323-329.CrossRef
81.
Gu YL, Yin LW, Zhang Z, Liu J, Liu SJ, Zhang LF, Wang TH: Neurotrophin expression in neural stem cells grafted acutely to transected spinal cord of adult rats linked to functional improvement. Cell Mol Neurobiol. 2012, 32: 1089-1097. 10.1007/s10571-012-9832-4.CrossRefPubMed
82.
Sowa Y, Imura T, Numajiri T, Nishino K, Fushiki S: Adipose-derived stem cells produce factors enhancing peripheral nerve regeneration: influence of age and anatomic site of origin. Stem Cells Dev. 2012, 21: 1852-1862. 10.1089/scd.2011.0403.CrossRefPubMed
83.
Ma XL, Liu KD, Li FC, Jiang XM, Jiang L, Li HL: Human mesenchymal stem cells increases expression of α-tubulin and angiopoietin 1 and 2 in focal cerebral ischemia and reperfusion. Curr Neurovasc Res. 2013, 10: 103-111. 10.2174/1567202611310020003.CrossRefPubMed
84.
Roales-Buján R, Páez P, Guerra M, Rodríguez S, Vío K, Ho-Plagaro A, García-Bonilla M, Rodríguez-Pérez LM, Domínguez-Pinos MD, Rodríguez EM, Pérez-Fígares JM, Jiménez AJ: Astrocytes acquire morphological and functional characteristics of ependymal cells following disruption of ependyma in hydrocephalus. Acta Neuropathol. 2012, 124: 531-546. 10.1007/s00401-012-0992-6.PubMedCentralCrossRefPubMed
85.
Brunt KR, Weisel RD, Li RK: Stem cells and regenerative medicine - future perspectives. Can J Physiol Pharmacol. 2012, 90: 327-335. 10.1139/y2012-007.CrossRefPubMed
86.
Kuwabara T, Asashima M: Regenerative medicine using adult neural stem cells: the potential for diabetes therapy and other pharmaceutical applications. J Mol Cell Biol. 2012, 4: 133-139. 10.1093/jmcb/mjs016.CrossRefPubMed
87.
Abdel-Salam OM: Stem cell therapy for Alzheimer disease. CNS Neurol Disord Drug Targets. 2011, 10: 459-485. 10.2174/187152711795563976.CrossRefPubMed
88.
Bjugstad KB, Teng YD, Redmond DE, Elsworth JD, Roth RH, Cornelius SK, Snyder EY, Sladek JR: Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson’s disease. Exp Neurol. 2008, 211: 362-369. 10.1016/j.expneurol.2008.01.025.PubMedCentralCrossRefPubMed
89.
Mc Bride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN, Kordower JH: Human neural stem cell transplants improve motor function in a rat model of Huntington’s disease. J Comp Neurol. 2004, 475: 211-219. 10.1002/cne.20176.CrossRef
90.
Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Del Carro U, Amadio S, Bergami A, Furlan R, Comi G, Vescovi AL, Martino G: Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature. 2003, 422: 688-699. 10.1038/nature01552.CrossRefPubMed
91.
Obermair FJ, Schröter A, Thallmair M: Endogenous neural progenitor cells as therapeutic target after spinal cord injury. Physiology (Bethesda). 2008, 23: 296-304. 10.1152/physiol.00017.2008.CrossRef
92.
Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, Masel J, Yenari MA, Weissman IL, Uchida N, Palmer T, Steinberg GK: Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci USA. 2004, 101: 11839-11844. 10.1073/pnas.0404474101.PubMedCentralCrossRefPubMed
93.
Tau GZ, Peterson BS: Normal development of brain circuits. Neuropsychopharmacol. 2010, 35: 147-168. 10.1038/npp.2009.115.CrossRef
Metadata
Title
Neural stem cells: are they the hope of a better life for patients with fetal-onset hydrocephalus?
Author
Montserrat Guerra
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Fluids and Barriers of the CNS / Issue 1/2014
Electronic ISSN: 2045-8118
DOI
https://doi.org/10.1186/2045-8118-11-7

Other articles of this Issue 1/2014

Fluids and Barriers of the CNS 1/2014 Go to the issue

Research

Cerebrospinal fluid is drained primarily via the spinal canal and olfactory route in young and aged spontaneously hypertensive rats

Short paper

Increased prevalence of cardiovascular disease in idiopathic normal pressure hydrocephalus patients compared to a population-based cohort from the HUNT3 survey

Review

Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood–brain barrier integrity?

Review

Brain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson’s disease

Research

Effect of transporter inhibition on the distribution of cefadroxil in rat brain

Research

Bacterial melanin crosses the blood–brain barrier in rat experimental model